Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2001 1
2002 1
2004 1
2005 1
2008 1
2011 1
2012 3
2013 2
2018 1
2019 1
2020 1
2021 1
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials.
Paulis G, Paulis A, Perletti G. Paulis G, et al. Arch Ital Urol Androl. 2021 Dec 21;93(4):475-480. doi: 10.4081/aiua.2021.4.475. Arch Ital Urol Androl. 2021. PMID: 34933534 Free article.
BACKGROUND: Serenoa repens (SR) is a plant used to treat benign prostatic hyperplasia and prostatitis. ...OBJECTIVE: The aim of this study is to investigate whether SR is causing negative effects on male sexual function. METHODS: To ascertain the effec …
BACKGROUND: Serenoa repens (SR) is a plant used to treat benign prostatic hyperplasia and prostatitis. ...OBJECTIVE: The aim o …
Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Ye Z, Huang J, Zhou L, Chen S, Wang Z, Ma L, Wang D, Wang G, Wang S, Liang C, Qiu S, Gu X, Liu J, Weng Z, Wu C, Wei Q, Xie L, Wu W, Cheng Y, Hu J, Wang Z, Zeng X. Ye Z, et al. Urology. 2019 Jul;129:172-179. doi: 10.1016/j.urology.2019.02.030. Epub 2019 Mar 14. Urology. 2019. PMID: 30880074 Clinical Trial.
METHODS: We conducted a double blind, placebo-controlled study of 354 patients with LUTS/BPH from 19 institutions, to evaluate the efficacy and safety of Serenoa repens. Participants were randomly assigned (1:1) into the Serenoa repens extract (320 mg) …
METHODS: We conducted a double blind, placebo-controlled study of 354 patients with LUTS/BPH from 19 institutions, to evaluate the efficacy …
Dietary Factors and Supplements Influencing Prostate Specific-Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials.
Grammatikopoulou MG, Gkiouras K, Papageorgiou SΤ, Myrogiannis I, Mykoniatis I, Papamitsou T, Bogdanos DP, Goulis DG. Grammatikopoulou MG, et al. Nutrients. 2020 Sep 29;12(10):2985. doi: 10.3390/nu12102985. Nutrients. 2020. PMID: 33003518 Free PMC article. Review.
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon( ) ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.
Vela-Navarrete R, Alcaraz A, Rodríguez-Antolín A, Miñana López B, Fernández-Gómez JM, Angulo JC, Castro Díaz D, Romero-Otero J, Brenes FJ, Carballido J, Molero García JM, Fernández-Pro Ledesma A, Cózar Olmos JM, Manasanch Dalmau J, Subirana Cachinero I, Herdman M, Ficarra V. Vela-Navarrete R, et al. BJU Int. 2018 Dec;122(6):1049-1065. doi: 10.1111/bju.14362. Epub 2018 Jun 6. BJU Int. 2018. PMID: 29694707 Free article.
OBJECTIVES: To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa repens (HESr, Permixon( ) ; Pierre Fabre Medicament, Castres, France), at a dose of 320 mg daily, as monotherapy for the treatment of lower urinary tract symptoms assoc …
OBJECTIVES: To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa repens (HESr, Permixon( ) ; …
Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study.
Bevilacqua G, Carino D, Salciccia S, Gentilucci A, Forte F, Marco MD, Pastore A, Martini M, Signore S, Calarco A, Recchia M, Voglino O, Maria VF, Viscuso P, Presicce F, Shehu E, Frisenda M, Sciarra A. Bevilacqua G, et al. Prostate. 2026 Feb;86(2):204-218. doi: 10.1002/pros.70071. Epub 2025 Oct 16. Prostate. 2026. PMID: 41098072 Clinical Trial.
This study evaluated the efficacy of combining a standardized extract of Serenoa repens (Sr) with alfuzosin versus alfuzosin monotherapy in men with LUTS due to BPH. ...Q(max) and nocturia also showed greater, although mild, improvements with combination therapy. …
This study evaluated the efficacy of combining a standardized extract of Serenoa repens (Sr) with alfuzosin versus alfuzosin m …
Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia.
Pytel YA, Vinarov A, Lopatkin N, Sivkov A, Gorilovsky L, Raynaud JP. Pytel YA, et al. Adv Ther. 2002 Nov-Dec;19(6):297-306. doi: 10.1007/BF02853175. Adv Ther. 2002. PMID: 12665050 Clinical Trial.
Permixon, the lipidosterolic extract of Serenoa repens, is widely used for the treatment of symptoms associated with benign prostatic hyperplasia (BPH). ...At 6, 12, 18, and 24 months, the International Prostate Symptom Score (I-PSS), quality of life, and sexual …
Permixon, the lipidosterolic extract of Serenoa repens, is widely used for the treatment of symptoms associated with benign pr …
Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia.
Wilde MI, Goa KL. Wilde MI, et al. Drugs. 1999 Apr;57(4):557-81. doi: 10.2165/00003495-199957040-00008. Drugs. 1999. PMID: 10235693 Review.
The overall efficacy of finasteride in patients with mild to moderate symptomatic BPH tended to be greater than that of serenoa repens (Permixon) in a 6-month trial. A US cost analysis model indicates that finasteride and terazosin are less expensive than transureth …
The overall efficacy of finasteride in patients with mild to moderate symptomatic BPH tended to be greater than that of serenoa re …
An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: results from the IDIProst Gold Study.
Cai T, Morgia G, Carrieri G, Terrone C, Imbimbo C, Verze P, Mirone V; IDIProst® Gold Study Group. Cai T, et al. Arch Ital Urol Androl. 2013 Dec 31;85(4):184-9. doi: 10.4081/aiua.2013.4.184. Arch Ital Urol Androl. 2013. PMID: 24399119 Free article. Clinical Trial.
The aim of this study was to evaluate the efficacy of the Alfa-5 association of Serenoa repens, Pinus massoniana Bark Extract (PMBE) and Crocus sativus (IDIProst Gold) in improvement of patient's quality of life, when compared with Serenoa repens alo …
The aim of this study was to evaluate the efficacy of the Alfa-5 association of Serenoa repens, Pinus massoniana Bark Extract …
Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.
Zlotta AR, Teillac P, Raynaud JP, Schulman CC. Zlotta AR, et al. Eur Urol. 2005 Aug;48(2):269-76. doi: 10.1016/j.eururo.2005.03.029. Epub 2005 Apr 18. Eur Urol. 2005. PMID: 15939527
We compared the influence on men's sexuality of Permixon, a lipido-sterolic extract of Serenoa Repens, with Tamsulosin and Finasteride using a specific validated questionnaire exploring patient's sexual functions. ...CONCLUSION: The present stud …
We compared the influence on men's sexuality of Permixon, a lipido-sterolic extract of Serenoa Repens, with Tamsulosin …
Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
Giulianelli R, Pecoraro S, Sepe G, Leonardi R, Gentile BC, Albanesi L, Brunori S, Mavilla L, Pisanti F, Giannella R, Morello P, Tuzzolo D, Coscione M, Galasso F, D'Angelo T, Ferravante P, Morelli E, Miragliuolo A; Cooperative Ur.O.P Group. Giulianelli R, et al. Arch Ital Urol Androl. 2012 Jun;84(2):94-8. Arch Ital Urol Androl. 2012. PMID: 22908779 Clinical Trial.
The objective of this study was to evaluate the efficacy of an extract of Serenoa repens (Permixon) in the treatment of lower urinary tract symptoms (LUTS) in patients with chronic benign prostate diseases with associated inflammation, also taking into consideration …
The objective of this study was to evaluate the efficacy of an extract of Serenoa repens (Permixon) in the treatment of lower …
17 results